Heart Failure

Biotronik announced that the U.S. Food and Drug Administration (FDA) has approved its DX line of implantable cardioverter defibrillators (ICDs) that can deliver ultra-high energy on the first shock. Also included in the approval response from the...

The U.S. Food and Drug Administration (FDA) approved Amgen’s ivabradine (Corlanor) to reduce hospitalization from worsening heart failure.

Results of a clinical trial announced at the American College of Cardiology Annual Scientific Session show a new type of therapy is safe and effective for symptomatic advanced heart failure patients already receiving optimum drug and dev...

CardioMEMS, heart failure, ACC.15, ACC 2015, Champion trial

Heart failure patients with reduced ejection fraction experienced significant HF mortality and hospitalization reductions via guideline-directed medical therapy managed by pulmonary artery pressure monitoring with the CardioMEMS HF System, accordi...

Thoratec, HeartMate II, ROADMAP
Thoratec Corp. announced results from the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management...
Sunshine Heart, C-Pulse, COUNTER HF, FDA, review, pause, enrollment
Sunshine Heart Inc. announced that the U.S. Food and Drug Administration (FDA) has reviewed the company’s submission regarding the pause of the COUNTER HF U.S...
Several futuristic technologies and their potential impact on healthcare were discussed during the Future of Cardiovascular Medicine track sessions at the...
Biotronik, DX, ICD, Inventra, Itrevia, FDA, ultra-high energy
Biotronik announced that the U.S. Food and Drug Administration (FDA) has approved its DX line of implantable cardioverter defibrillators (ICDs) that can...
Biotronik, DX, ICD, Inventra, Itrevia, FDA, ultra-high energy
Biotronik announced that the U.S. Food and Drug Administration (FDA) has approved its DX line of implantable cardioverter defibrillators (
Cardiovascular Systems Inc. announced that it has received U.S. Food and Drug Administration (FDA) clearance for the 4 French, 1.25 Solid...
The HD Medical Inc. ViScope visual stethoscope product family provides dynamic auscultation — the ability to see what you hear. ViScope’s...

Articles

3D printing, 3-D printing
Several futuristic technologies and their potential impact on healthcare were discussed during the Future of Cardiovascular Medicine track sessions at the...
ivabradine (Corlanor)
The U.S. Food and Drug Administration (FDA) approved Amgen’s ivabradine (Corlanor) to reduce hospitalization from worsening heart failure.
catheter ablation, Afib, Amiodarone, Luigi Di Biase, ACC, heart failure
Patients with heart failure and atrial fibrillation were less likely to experience death, hospitalization or recurrent Afib with catheter ablation than with a...
Bendavia, heart attack, scarring, angioplasty, ACC, study
Patients who received the new drug Bendavia before undergoing angioplasty or stent implantation after a heart attack showed no significant reduction in...

Video Center

U.S. healthcare reform is largely being driven through adoption of new information technology (IT...
1 week 4 days ago
The biggest technology news coming out of the 2015 American College of Cardiology (ACC) annual...
5 weeks 4 days ago
It’s been no secret that the American healthcare system needed to change to survive economically...
11 weeks 4 days ago
Centricity, webinar, ZFV, ZFP, viewer, remote viewing system, enterprise
Healthcare organizations are demanding more capabilities for image viewers accessed by clinicians. Zero footprint (ZFP) viewers provide imaging tools from...
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...

Comparison Charts

Sorry there is no data available